GET Journal of Biosecurity and One Health

GET Journal of Biosecurity and One Health

Antidiabetic and Nephroprotective Effects of Aqueous Leaf Extracts of Moringa oleifera in Alloxan-Induced Diabetic Rats

Authors: Josiah JG1; Jiya Z2; Tswanya MN3; Adama JY4+; Eke SS5; Mathew JT

ORCID ID: https://orcid.org/0000-0001-6983-0043

GET Journal of Biosecurity and One Health, Volume 4, Issue 1.

Article Keywords: Tessellation; Disease mapping; CKDu; Spatial

DOI

Journal Volume & Issue

Volume 4, Issue 1

GET JOURNAL OF BIOSECURITY AND ONE HEALTH

Volume 1, No. 4, 2022

Pages 34-40

Ebola Survivors are not at Increased Risk for Gynecologic Surgeries

Gorpudolo-Dennis N1; Kennedy SB2*; Reilly C3 and Sankoh M1

1Department of Obstetrics and Gynecology, Redemption Hospital, New Kru Town, Montserrado County, Monrovia, Liberia.

2UL-PIRE Africa Center, An Infectious Disease Research Center, Ground Floor, Graduate School Building, University of Liberia, Monrovia, Liberia.

3Department of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA.

*Corresponding Author: Stephen B. Kennedy, MD, MPH, UL-PIRE Africa Center, An Infectious Disease Research Center
Ground Floor, Graduate School Building, University of Liberia, Monrovia, Liberia. Tel: +231 770 645 830

Orchid No: http://orcid.org/0000-0002-0318-930X

ABSTRACT

As the result of multiple signs and symptoms, and complications observed among survivors of the Ebola virus disease (EVD), there is an assumption that survivors might experience perturbations within their clotting parameters. This may eventually lead to increased bleeding time, predisposing them to increased risk for surgical complications. This study aimed to comparatively review specific intra-operative parameters such as uterine fibroids and polyps among a number of EVD survivors and non survivors undergoing elective gynecologic surgeries at Redemption Hospital, a tertiary specialized referral hospital located within one of the EVD hotspots, in Liberia from January to October 2016. A case-control study was conducted wherein cases were referred from the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), an EVD clinical trial platform, while controls were sampled from the general patient population, at Redemption Hospital. The controls were matched based on age, employment status and parity. All surgeries were performed by single surgeon based on a surgical checklist that included designated intra- and post-operative parameters. Statistical analysis such as counts, percentiles, confidence intervals and relative risks were performed to assess the differences between the cases and controls, respectively. Survivors were between the ages of 42 years and 44 years for controls with an average interval between discharge from the Ebola Treatment Unit (ETU) and surgical intervention of greater than one year. The median duration of surgical procedure was 60 minutes and blood loss of 250 ml in both groups. Besides the relative risks (RR) of receiving antibiotics for more than 3 days of 1.5 (85.7% vs. 57.1%) and hospitalization of more than 7 days of 0.25 (14% vs. 57%) for survivors as compared to controls, most of the indicators were not significantly different. The findings revealed that EVD survivors who present with benign tumors such as uterine fibroids, polyps, or adenomyosis, requiring elective uterine surgery such as myomectomy and/or hysterectomy are generally not at increased risk of surgical complications because most of the indicators (hospitalization, blood loss, antibiotics, etc.) were not significantly different between the two groups. Findings from this study may potentially revise the approaches used by gynecologists and general surgeons during encounters and/or interventions with patient(s) concerning emerging infectious diseases (EIDs).

Keywords: Ebola Virus Disease (EVD), Emerging Infectious Diseases (EIDs), Ebola Survivors, Uterine Surgery, Females, Liberia

Abstract

Diabetes mellitus (DM) is a global burden, associated with life-threatening complications which include renal failure, cardiac attack and stroke. This study was carried out to investigate the antidiabetic and nephroprotective effects of aqueous leaf extracts of Moringa oleifera in rats with alloxan-induced diabetes. For this purpose, twenty-five adult Wistar rats with body weight of 150-250g were randomly assigned to groups of five rats each (n=5). Group A served as normal control; group B served as diabetes control; group C served as positive control and group D and E were diabetic groups administered with the aqueous leaf extracts. Blood samples were collected to determine the fasting blood glucose level, creatinine and urea. The results from this study showed that the aqueous leaf extract of Moringa oleifera demonstrated significant antidiabetic activity by reducing blood glucose levels by 34.7% and 36% when lower and higher doses of extracts of M. oleifera were administered to rats respectively and also showed an improvement in glucose tolerance in the diabetic rats. Additionally, the extract demonstrated nephroprotective effects by reducing markers of kidney damage and improving kidney functions in the diabetic rats. This was evident in the reduction of urea and Creatinine levels when compared to positive and negative control groups. The findings suggest that M. oleifera leaf extracts may have potential therapeutic benefits for managing diabetes and protecting against kidney damage. Further research on other parts of the plant is recommended to elucidate its mechanism of action and active compounds.